Short Interest in Definitive Healthcare Corp. (NASDAQ:DH) Declines By 5.9%

Definitive Healthcare Corp. (NASDAQ:DH) saw a significant drop in short interest in the month of August. As of August 15th, there was short interest totalling 3,210,000 shares, a drop of 5.9% from the July 31st total of 3,410,000 shares. Approximately 6.6% of the company’s stock are short sold. Based on an average daily volume of 1,120,000 shares, the short-interest ratio is currently 2.9 days.

Definitive Healthcare Stock Down 1.5 %

Shares of Definitive Healthcare stock opened at $4.62 on Wednesday. The company has a market capitalization of $544.86 million, a P/E ratio of -2.64, a PEG ratio of 6.78 and a beta of 1.30. The business’s fifty day moving average price is $4.85 and its two-hundred day moving average price is $6.27. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.40 and a quick ratio of 2.40. Definitive Healthcare has a 1-year low of $3.19 and a 1-year high of $10.62.

Definitive Healthcare (NASDAQ:DH) last released its quarterly earnings results on Monday, August 5th. The company reported $0.09 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.09. Definitive Healthcare had a negative net margin of 156.65% and a positive return on equity of 0.98%. The company had revenue of $63.70 million during the quarter, compared to analysts’ expectations of $63.19 million. During the same period in the prior year, the company earned $0.08 earnings per share. The business’s quarterly revenue was up 4.4% compared to the same quarter last year. As a group, research analysts forecast that Definitive Healthcare will post 0.08 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on DH shares. Barclays reduced their price target on Definitive Healthcare from $6.00 to $4.00 and set an “equal weight” rating for the company in a report on Wednesday, August 7th. Canaccord Genuity Group reduced their target price on Definitive Healthcare from $10.00 to $8.00 and set a “hold” rating for the company in a research note on Wednesday, May 8th. Robert W. Baird decreased their price target on shares of Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating for the company in a research report on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft cut their price target on shares of Definitive Healthcare from $7.00 to $5.00 and set a “hold” rating on the stock in a report on Friday, August 9th. Finally, JPMorgan Chase & Co. lowered shares of Definitive Healthcare from a “neutral” rating to an “underweight” rating and decreased their price objective for the stock from $7.00 to $5.00 in a report on Wednesday, July 31st. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company. According to MarketBeat.com, Definitive Healthcare presently has an average rating of “Hold” and an average target price of $5.64.

Institutional Trading of Definitive Healthcare

A number of hedge funds have recently modified their holdings of DH. Norden Group LLC acquired a new stake in Definitive Healthcare during the first quarter valued at approximately $83,000. Canada Pension Plan Investment Board bought a new position in shares of Definitive Healthcare during the second quarter valued at $109,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of Definitive Healthcare by 31.4% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 21,292 shares of the company’s stock valued at $116,000 after acquiring an additional 5,083 shares during the period. Susquehanna Fundamental Investments LLC acquired a new position in Definitive Healthcare in the first quarter valued at about $120,000. Finally, The Manufacturers Life Insurance Company grew its position in Definitive Healthcare by 17.0% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 22,896 shares of the company’s stock worth $125,000 after acquiring an additional 3,332 shares during the last quarter. Institutional investors own 98.67% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.